GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » Revenue

Shenzhen YHLO Biotech Co (SHSE:688575) Revenue : ¥1,902 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co Revenue?

Shenzhen YHLO Biotech Co's revenue for the three months ended in Sep. 2024 was ¥434 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1,902 Mil. Shenzhen YHLO Biotech Co's Revenue per Share for the three months ended in Sep. 2024 was ¥0.76. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥3.29.

Warning Sign:

Shenzhen YHLO Biotech Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Shenzhen YHLO Biotech Co was -21.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 22.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 7 years, Shenzhen YHLO Biotech Co's highest 3-Year average Revenue per Share Growth Rate was 58.80% per year. The lowest was 13.20% per year. And the median was 18.70% per year.


Shenzhen YHLO Biotech Co Revenue Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co Revenue Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 877.36 999.01 1,177.90 3,980.76 2,053.10

Shenzhen YHLO Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 469.97 508.16 431.32 528.71 433.83

Competitive Comparison of Shenzhen YHLO Biotech Co's Revenue

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Revenue distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's Revenue falls into.


;
;

Shenzhen YHLO Biotech Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,902 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen YHLO Biotech Co  (SHSE:688575) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Shenzhen YHLO Biotech Co Revenue Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Song Yong Bo Directors, senior managers
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines